COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)

Clinical trial NCT00132899 · COMPLETED

Trial details

NCT number: NCT00132899
Sponsor: University of Western Ontario, Canada
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2005-12-01
Primary completion: 2008-02-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.